| Literature DB >> 33034769 |
Manan Binth Taj Noor1, Nusrat Zerin Zenia1, M Shamim Kaiser2, Shamim Al Mamun1, Mufti Mahmud3.
Abstract
Neuroimaging, in particular magnetic resonance imaging (MRI), has been playing an important role in understanding brain functionalities and its disorders during the last couple of decades. These cutting-edge MRI scans, supported by high-performance computational tools and novel ML techniques, have opened up possibilities to unprecedentedly identify neurological disorders. However, similarities in disease phenotypes make it very difficult to detect such disorders accurately from the acquired neuroimaging data. This article critically examines and compares performances of the existing deep learning (DL)-based methods to detect neurological disorders-focusing on Alzheimer's disease, Parkinson's disease and schizophrenia-from MRI data acquired using different modalities including functional and structural MRI. The comparative performance analysis of various DL architectures across different disorders and imaging modalities suggests that the Convolutional Neural Network outperforms other methods in detecting neurological disorders. Towards the end, a number of current research challenges are indicated and some possible future research directions are provided.Entities:
Keywords: Alzheimer’s disease; Machine learning; Neuroimaging; Parkinson’s disease; Schizophrenia
Year: 2020 PMID: 33034769 PMCID: PMC7547060 DOI: 10.1186/s40708-020-00112-2
Source DB: PubMed Journal: Brain Inform ISSN: 2198-4026
Fig. 1Peer-reviewed research results published during the last 5 years reporting the usage of DL in detecting NLD from MRI data. The Scopus database (https://www.scopus.com/) was searched with search-strings containing keywords “Deep learning” and “MRI” in conjunction with each of the NLD (“Alzheimer’s”, “Parkinson’s”, and “schizophrenia”) and the obtained results were categorized basing on the DL architectures (a) and diseases (b). A. In the literature the CNN has been reported much more frequently in comparison to the RNN, LSTM, DNN, and AE. B. The main effort appears to cluster around AD in comparison to PD and SZ
Fig. 2Overview of DL-based prediction and classification pipeline of neurodegenerative disease from different variants of MRI
Fig. 3DL Architecture
Data pre-processing techniques applied to MRI and fMRI images
| Type | Ref. | Technique (applied methods) |
|---|---|---|
| Scaling | [ | Image resize |
| [ | Image registration ( AR | |
| [ | Intensity non-uniformity correction (GW | |
| [ | Distortion correction (PB | |
| [ | Bias correction/regularization (MICO | |
| [ | Contrast enhancement (CLAHE | |
| Correction | [ | Slice timing correction (HSI |
| [ | Motion correction (FSL-MCFLIRT | |
| Stripping and trimming | [ | Skull stripping (NRBAC |
| [ | Brain extraction (FSL-BET | |
| [ | Trim edges | |
| Normalization | [ | Normalization (SPM |
| [ | Intensity normalization | |
| [ | Spatial normalization (ALT | |
| [ | Z-score normalization | |
| [ | Numerical normalization | |
| Filtering | [ | Basic filtering (GSF |
| [ | Spatial filtering | |
| [ | Temporal filtering | |
| [ | Weiner filtering | |
| [ | High-pass filtering | |
| Smoothing | [ | Basic smoothing (FWHM-GK |
| [ | Spatial smoothing (FWHM-GK | |
| Distinct techniques | [ | Linear regression |
| [ | Linear detrend | |
| [ | Modulation (JWF | |
| [ | Segmentation (LLL | |
| [ | Voxel-based morphometric | |
| [ | Cortical reconstruction | |
| [ | Denoising (tCompCor | |
| [ | Data augmentation |
FWHM-GK Full-width half-maximum (FWHM) Gaussian kernel, SPM statistical parametric mapping, SD standardization, ALT affine linear transformation, JWF Jacobian of wrap field, GSF Gaussian smoothing filter, FST Free Surfer Tool, ANTs advanced normalization tools, GW Gradwarp, B1-NU B1-non-uniformity, PB phantom based, FSL-BET FMRIB Software Library-Brain Extraction Tool, FSL-MCFLIRT motion correction using FMRIB’s linear image registration tool, FSL-FLIRT FMRIB’s linear image registration tool, FEAT FMRI expert analysis tool, CLAHE contrast limited adaptive histogram equalization, LLL local label learning, DARTEL diffeomorphic anatomical registration through exponentiated Lie algebra, LR linear registration, LSA least square approach, 6-PST 6 parameter spatial transformation, EPI echo planar imaging, NRBAC nonparametric region-based active contour, MICO multiplicative intrinsic component optimization
1MRI
2fMRI
Summary of DL-based studies for prediction and classification of AD from MRI
| Ref. | Reg. | DL Arch. | Pre-Proc. | Features | Dataset | Size | Accuracy |
|---|---|---|---|---|---|---|---|
| [ | WB | SAE-3D, CNN | NM | CBF | ADNI | 755 (AD, MCI, HC) | 3-way 89.47%, AD vs. HC 95.39%, AD vs. MCI 86.84%, HC vs. MCI 92.11% |
| [ | CNN | MC, STC, SS, HPF, SN, WMS, MD | SSIF | ADNI | 52 AD | 99.9% | |
| [ | CNN | MC, SST, HPF | SSIF | ADNI | 28 AD, 15 NC | 96.86% | |
| [ | CNN | SN, BC, MD | CBF | ADNI | 33 AD, 22 LMCI, 49 MCI, 45 HC | 98.88% | |
| [ | CNN | INUC, DC, NM | ADNI | 193 AD, 151 HC | Class Score 95% | ||
| [ | DNN | HPCV, CFV, LVV, ECT, MMSE | ADNI | 60 AD, 60 HC, 60 cMCI 60 MCI | 34.8% | ||
| [ | 3D-CNN | CR, TE, IRE, IN | 3D CBF | ADNI | 199 AD, 141 NC; 3D MRI AD 600 NC 598 | 98.74% | |
| [ | 3D-CNN | SST, NM | CBF | ADNI | 50 AD, 43 LMCI, 77 EMCI, 61 NC | ||
| [ | PNN | IR, WF | GLCM, SED | ADNI | 85% | ||
| [ | VAE, MLP | SG | Shape feature | ADNI | 150 NC, 90 AD, 160 EMCI, 160 LMCI | NC-AD 84%, NC-EMCI 56%, NC-LMCI 59%. AD-EMCI 81%, AD-LMCI 57%, EMCI-LMCI 63% | |
| [ | DBN | VBM | VV 3611, MSD 24 | OASIS | 49 AD, 49 HC | MSD 0.7360 | |
| [ | CNN | BE, MC, STC, IM, SS, THPF, NM, SN | CBF | ADNI | 25 CN, 25 SMC, 25 EMCI, 25 LMCI, 13 MCI, 25 AD | CN 100%, SMC 96.85%, EMCI 97.38%, LMCI 97.43%, MCI 97.40%, AD 98.01% | |
| [ | BL | 3D-CNN | NNM, BE, IR | 4D features, clinical features | ADNI | 192 AD, 184 HC, 181 pMCI, 228 sMCI | 86% |
| [ | HPC | CNN | IR, SG | HPC shape, texture, CBF | ADNI-1, ADNI- GO&2, AIBL | ADNI: 1711, AIBL: 435 | |
| [ | LSTM-RNN | LSTM-based features | ADNI-1, ADNI-GO&2 | 822 MCI | |||
| [ | CSA | SAE-DNN | MC, NUC, IN, SST, VL | 310 Vol., CorTh, SAF, 5000 FDCM | ADNI, CAD- Dementia | 171 CN, 232 MCI, 101 AD | Model-1 ADNI 56.6% |
| [ | MCS | CNN | INUC | CBF | ADNI | 47 AD 34 NC | |
| [ | SCS | CNN | CBF | OASIS | 100 AD, 100 HC | VGG16: 92.3% | |
| [ | CNN | NM, IR, MD | CBF | ADNI, Milan | ADNI: 294 PAD, 763 MCI, 352 HC Milan: 124 PAD, 50 MCI, 55 HC | ADNI: 99% | |
| [ | CNN | CBF, 64 | OASIS | 416 | 80.25% | ||
| [ | VB | CNN | SST, DA, CE, F | CBF | OASIS, MIRIAD | OASIS: 30 AD, 70 MCI, 316 HC MIRIAD: 46 MCI, 23 HC | 0.8 |
Ref reference, Reg region, DL Arch deep learning architecture, Pre-Proc pre-processing technique used in the study, WB whole brain, BL-brain lobes HPC–hippocampus, CSA cortical surface area, MCS middle cross section, SCS single cross section, SSIF shift and scale-invariant features; Vol.-volume; CorTh-cortical thickness; SAF-surface area features; HPCV-hippocampal volumes; CFV-cerebrospinal fluid volume; LVV-lateral ventricle volume; ECT-entorhinal cortex thickness; MMSE-baseline scores of Mini-Mental State examination; -n-fold cross-validation, 4DF 4D features, CF clinical features, GLCM gray-level co-occurrence matrix, SED Sobel edge detector, MSD-maximal self-dissimilarity, VV voxel values
Summary of DL-based studies for prediction and classification of PD from [s]-MRI
| Ref. | Regions | DL Tech. | Pre-Proc. | Feature | Dataset | Size | Accuracy |
|---|---|---|---|---|---|---|---|
| [ | Axial | CNN-RNN | – | CBFd | NTUA | 55 PD, 23 PD Synd | 98% |
| [ | Sagittal, coronal, axial planes | 3D-CNN | SST, DA | CNN based, age, sex | PPMI | 452 PD, 204 HC | 100% |
| [ | Mild brain | CNN | CBF | NIMHANS | 45 PD, 20 APS, 35 HC | 80% | |
| [ | Lentiform nucleus | CNN-RNN | CNN based | NTUA | 66176 | 98% | |
| [ | Whole brain | CNN | NM, F, SM | CBF | PPMI | 100 PD, 82 HC | 88.9% |
| [ | Basal ganglia, mesencephalon | CNN | AC, BR, SN, SM | CNN based | PPMI | Control vs PD 94.5-96%, PD vs SWEDD 88.7% |
Pre-Proc. pre-processing, Synd syndrome, – n fold cross-validation, AC alignment correction, SWEDD scans without evidence for dopaminergic deficit, CBF CNN-based features
Summery of DL-based studies for prediction and classification of SZ from MRI
| Ref. | Regions | DL | Pre-Proc. | Feature (count) | Dataset | Size | Accuracy |
|---|---|---|---|---|---|---|---|
| [ | VFN, CN, DMN | 3D-CNN | MC, DN, STC, SS, TF, HPF | 3D-ICA (15) | COBRE | 72 SZs,74 HCs | 98.09% |
| [ | AUD, DMN | 2D-CNN | MC, SN, SS | ICA(13) | Self | 42 SZs,40 HCs | slice-level DMN-72.65% |
| [ | WB | DNN | ICA | FNC, SBM (10) | MRN | 69 SZs, 75 HCs | 94.4% |
| [ | WB | DNN | ROI (116) | OpenfMRI | 50 SZs, 49 BD, 122 HCs | 76.6% | |
| [ | WB | RNN | MC, DN, SF, TF, NM, LRg | SPF | FBIRN phase-II | 87 SZs, 85 HCs | 64% |
| [ | WB | DNN | STC, SN, SS | FNC (116) | COBRE | 72 SZs,74 HCs | 95.4% |
| [ | WB | DNN | FNC,SBM (410) | MLSP | |||
| [ | WB | DBN | LR, ZN | NMF | Multisite | 143 SZs,83 HCs | 73.6% |
| [ | WB | SAE | STC, MC,SN, SM, F | VTS | COBRE | 72 SZs,74 HCs | 92% |
| [ | Atlas | FFBPNN | STC, MC, TF, NM, SS | FNC (20) | Hospital | 39 SZs,31 HCs | 79.3% |
| [ | WB | DNN, LRP | MC, SN | FNC, ICA (1225) | Multisite | 558 SZs, 542 HCs | 84.75% |
| [ | Cor., Str., Cere. | DNN | MC, NM, STC, SS, LD, TF | FNC (116) | Multisite | 474 SZs,607 HCs | |
| [ | Vent. | DBN | SST, BC, SG | SV, ROI | COBRE | 72 SZs,76 HCs | ROI-83.3% |
| [ | WB | MLP | ICA, RV | FBIRN | 135 SZs,169 HCs | AUC- 0.85 | |
| [ | WB | MLP | NM, SG, SS | Multisite | 198 SZs,191 HCs | AUC-0.75 |
WB whole brain, Cor. cortical, Str. striatal, Cere cerebellar, Vent. ventricle, MRN mild research network, VFN visual frontal network, AUD auditory cortex, CN cerebellar network, DMN default mode network, n-fold cross-validation, SPF spatial feature, NMF neuro-morphometric features, VTS voxel time series, SV segmented ventricle, Self self-generated dataset
Open source datasets containing data of neurodegenerative disorders
| Ref. | Dataset | Description |
|---|---|---|
| [ | ADNI | Alzheimer’s Disease Neuroimaging Initiative (ADNI) contains MRI data for detecting and tracking AD |
| [ | COBRE | The Center for Biomedical Research Excellence (COBRE) dataset includes MR data of 147 subject where 72 patients are suffering from schizophrenia |
| [ | fastMRI | It gives 1.5/3T MR data from 6,970 fully sampled brain data of axial T1/T2 and FLAIR images |
| [ | FBIRN | Function Biomedical Informatics Research Network (FBIRN) Phase 1 consists of 5 traveling healthy subjects (age: 20–29 years) each scanned with sMRI and fMRI on 10 different 1.5 to 4 T scanners, FBIRN Phase 2 (87 SZ and 85 HC, age: 18–70) and Phase 3 datasets (186 HC, 176 SZ, age: 18–62) consist of subjects with SZ or schizoaffective disorder along with HC scanned at multiple sites |
| [ | FITBIR | Along with the other Imaging datasets, the Federal Interagency Traumatic Brain Injury Research (FITBIR) includes the open source datasets for AD |
| [ | Kaggle | It contains mild-to-moderate dementia dataset which is 72 subsets data taken from Open Access Series of Imaging Studies (OASIS) dataset |
| [ | NAMIC | National Alliance for Medical Image Computing (NAMIC) provides Brain Mutlimodality datasets |
| [ | NTUA | It consists of MRI and DAT scan of those who are suffering from PD and also some NC |
| [ | OASIS | OASIS-3, OASIS-2 and OASIS-1 contain 373 MRI data of 150 subjects, 434 MRI data of 416 subjects and 2168 MRI data of 1098 subjects, respectively |
| [ | MIRIAD | The MIRIAD dataset contains volumetric MRI brain-scans of AD sufferers and HC elderly people. This database consists of 46 mild–moderate Alzheimer’s subjects and 23 controls |
| [ | Open fMRI | It contains 95 MRI datasets of 3372 subjects and can be used detect AD and PD |
| [ | PPMI | Parkinson’s Progression Markers Initiative (PPMI) database accommodates raw and processed MRI of parkinson’s progression data |
Summery of various DL methods and datasets used in detecting NLD
| NLD | DL methods | Datasets |
|---|---|---|
| AD | CNN | ADNI, OASIS |
| PD | CNN | NTUA, PPMI |
| SZ | DNN, CNN | COBRE, FBIRN |
Fig. 4Performance comparison of application of various DLs in detecting neurological disorders from MRI datasets. The normalized performance for a Alzheimer’s disease, b schizophrenia and c Parkinson’s disease detection shows which method works well on which type of disease. The height of the bars denote the range of performance values reported in the literature